NEW YORK (GenomeWeb) – Affymetrix today announced a global partnership with Athletigen Technologies to use the Axiom genotyping platform in its sports-related direct-to-consumer genetic analysis service.
The Athletigen microarray analyzes 850,000 genetic variants that it claims can influence human athletic performance.
Financial and other terms of the agreement were not disclosed.
The deal with Athletigen is the most recent in a series of agreements covering use of Affymetrix's Axiom platform for a variety of applications. Last month, the Green Super Rice Project selected the Axiom platform for genotyping in its molecular breeding activities. In July, Affymetrix allied with BioRealm and RUCDR Infinite Biologics to genotype the National Institute of Drug Abuse biorepository.